PubRank

Annarita Destro

Author PubWeight™ 33.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci Transl Med 2011 4.51
2 Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. J Clin Oncol 2009 3.57
3 Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma. Hepatology 2011 2.36
4 The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol 2008 2.03
5 Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007 1.81
6 The critical role of agrin in the hematopoietic stem cell niche. Blood 2011 1.54
7 Modular structure of the human lamin B2 replicator. Mol Cell Biol 2004 1.46
8 Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin. Clin Cancer Res 2011 1.35
9 The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma. Cancer Res 2008 1.30
10 Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Hepatology 2002 1.30
11 MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma. Liver Int 2012 1.18
12 Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology 2007 1.15
13 Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program. Clin Cancer Res 2008 1.04
14 Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver. BMC Cancer 2006 0.98
15 Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. Eur J Cancer 2010 0.87
16 Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases. Cancer 2012 0.86
17 Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2013 0.83
18 Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases. Hum Pathol 2008 0.83
19 Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors. Tumori 2011 0.80
20 Combined hepatocellular carcinoma - cholangiocarcinoma harboring a metastasis of colon adenocarcinoma. J Gastrointestin Liver Dis 2013 0.80
21 p95HER2 truncated form in resected non-small cell lung cancer. J Thorac Oncol 2012 0.80
22 Cracking spaces in Hashimoto Thyroiditis are lymphatic and prelymphatic vessels: a gift of immunohistochemistry for the centenary of Hashimoto's description. Am J Surg Pathol 2010 0.79
23 Anatomic location of breast cancer micrometastasis in sentinel lymph node predicts axillary status. Ann Surg 2006 0.77
24 An exploratory biomarker study in metastatic tumors from colorectal cancer patients treated with bevacizumab. Int J Biol Markers 2015 0.76